Simply Solventless Concentrates Ltd. Stock
Stocks
HASH
CA82888A1021
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Toronto S.E.
2026-10-20
|
5-day change | 1st Jan Change | ||
| 0.0450 CAD | -10.00% |
|
-18.18% | -67.86% |
| Market Cap | 5.2M 3.7M 3.29M 3.05M 2.76M 349M 5.26M 36.55M 14.34M 183M 13.86M 13.57M 584M | P/E 2024 |
-10x | P/E 2025 | -0.58x |
|---|---|---|---|---|---|
| Enterprise Value | 22.2M 15.78M 14.06M 13.02M 11.78M 1.49B 22.46M 156M 61.26M 783M 59.21M 57.97M 2.49B | EV / Sales 2024 |
6.8x | EV / Sales 2025 | 1.14x |
| Free-Float |
80.79% | Yield 2024 * |
-
| Yield 2025 | - |
Toronto S.E.CAD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| HASH | End-of-day quote | |
OTC Markets
| SSLCF | Delayed | |
|
Deutsche Boerse AG
| Y3I | Delayed |
| 1 day | -10.00% | ||
| 1 week | -18.18% | ||
| 1 month | -10.00% | ||
| 3 months | -30.77% | ||
| 6 months | +12.50% | ||
| Current year | -67.86% |
| 1 week | 0.04 |  | 0.06 |
| 1 month | 0.04 | | 0.06 |
| Current year | 0.04 | | 0.19 |
| 1 year | 0.04 | | 0.26 |
| 3 years | 0.04 | | 0.84 |
| 5 years | 0.04 | | 0.84 |
| 10 years | 0.04 | | 0.84 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/10/26 | Buy | Director | 5,500 | 0.0057% | ||
| 2/10/26 | Buy | Director | 5,000 | 0.0052% | ||
| 2/10/26 | Buy | Director | 9,500 | 0.0098% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -10.00% | -18.18% | -81.25% | -82.69% | 3.7M | |
| -1.01% | +5.13% | +58.93% | +120.37% | 1,144B | |
| -0.61% | +1.52% | +34.34% | +70.28% | 625B | |
| -1.48% | +0.47% | +23.08% | +96.78% | 511B | |
| +0.54% | +8.95% | +39.45% | +64.02% | 377B | |
| +1.07% | +1.70% | +71.06% | +45.02% | 366B | |
| +0.30% | +6.35% | +21.84% | +49.62% | 291B | |
| -0.03% | +6.04% | +0.40% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +60.53% | 237B | |
| -1.88% | +0.02% | +23.77% | +98.00% | 194B | |
| Average | -1.63% | +3.86% | +23.72% | +54.29% | 400.79B | |
| Weighted average by Cap. | -0.64% | +6.91% | +40.78% | +81.10% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.68M 9.72M 8.67M 8.02M 7.26M 918M 13.84M 96.19M 37.74M 482M 36.48M 35.72M 1.54B | 29.06M 20.66M 18.41M 17.04M 15.42M 1.95B 29.4M 204M 80.18M 1.02B 77.5M 75.88M 3.27B |
| Net income | -5.19M -3.69M -3.29M -3.05M -2.76M -348M -5.26M -36.53M -14.33M -183M -13.85M -13.57M -584M | -27.33M -19.43M -17.31M -16.03M -14.51M -1.83B -27.65M -192M -75.41M -964M -72.88M -71.36M -3.07B |
| Net Debt | 9.1M 6.47M 5.76M 5.34M 4.83M 610M 9.21M 63.99M 25.11M 321M 24.27M 23.76M 1.02B | 17M 12.09M 10.77M 9.97M 9.02M 1.14B 17.2M 120M 46.92M 600M 45.35M 44.4M 1.91B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | CA$0.0450 | -10.00% | 10,021 |
| 26-10-19 | CA$0.0500 | -9.09% | 47,500 |
| 26-10-15 | CA$0.0550 | 0.00% | 6,000 |
| 26-10-14 | CA$0.0550 | 0.00% | 19,000 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- HASH Stock
Select your edition
All financial news and data tailored to specific country editions
